Bed Bath & Beyond, Inc.

As of June 30, 2026, Bed Bath & Beyond, Inc. carries a market capitalization of 9.41B, placing it among publicly traded companies globally. Its enterprise value stands at 10.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bed Bath & Beyond, Inc.'s next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Bed Bath & Beyond, Inc. has 81.76M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.39, and the price-to-book ratio stands at 2.51.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.52 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 10.35B versus a market cap of 9.41B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bed Bath & Beyond, Inc. maintains a current ratio of 0.76, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Bed Bath & Beyond, Inc. posted a negative return on equity (ROE) of -47.04, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.39, reflecting losses generated across the asset base. The company generates approximately 44.82M in revenue per employee across its workforce of 444.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 28.11 indicates how many times Bed Bath & Beyond, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bed Bath & Beyond, Inc. recorded an income tax benefit of -33.60M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -1.45B and -1.42B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 5, 2026, Bed Bath & Beyond, Inc.'s stock has gained approximately 6552.54% over the past 52 weeks. The 50-day moving average sits at 115.90, while the 200-day moving average is 76.61.

Over the twelve months ended June 30, 2026, Bed Bath & Beyond, Inc. generated 19.91B in revenue and converted that into -1.42B in net income, yielding earnings per share of -20.84. EBITDA reached -1.19B, while operating income came in at -1.51B.

As of June 30, 2026, Bed Bath & Beyond, Inc. holds 1.74B in cash and equivalents against 2.67B in total debt, resulting in a net debt position of -1.10B. Total book value stands at 3.75B, with working capital of -1.31B providing operational flexibility.

Bed Bath & Beyond, Inc. produced -1.25B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -206.01M in capital expenditures, free cash flow totaled -1.46B - equivalent to -21.40 per share.

Over the twelve months ended June 30, 2026, Bed Bath & Beyond, Inc. posted a gross margin of 25.30, reflecting its pricing power and cost economics. The operating margin of -7.61 and net profit margin of -7.13 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -18.59: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -22.08, meaning Bed Bath & Beyond, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Bed Bath & Beyond, Inc. has an Altman Z-Score of -0.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.